Clinical trials
Terminated Phase 4 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 4 |
| 2016 | 5 |
| 2017 | 6 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 1 |
| 2023 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 55 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma China, Inc. | 4 |
| Merck KGaA, Darmstadt, Germany | 4 |
| Peking University First Hospital | 4 |
| AstraZeneca | 2 |
| Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | 2 |
| Shandong Cancer Hospital and Institute | 2 |
| Wei Hao | 2 |
| Actelion | 1 |
| Astellas Pharma Inc | 1 |
| Capital Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 3 |
| Pulmonary Arterial Hypertension | 3 |
| Aspergillosis | 2 |
| Candidiasis | 2 |
| Carcinoma, Hepatocellular | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Diabetes Mellitus | 2 |
| Esophageal Neoplasms | 2 |
| Heart Failure | 2 |
| Renal Insufficiency, Chronic | 2 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.